Letix

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Letix

What is Letix? (Overview and Quick Facts)

Letix is a prescription medicine categorized as a third-generation cephalosporin antibiotic. It is primarily used to treat infections caused by susceptible bacteria, particularly those affecting the respiratory and urinary tracts.

Property Description
Active Ingredient Cefixime
Form Oral Solid Dosage (Tablet/Dispersible Tablet) or Syrup
Pharmacological Class Third-Generation Cephalosporin Antibiotic
General Purpose Treatment of Bacterial Infections
Status Prescription Only (Rx)

What Type of Therapeutic Agent is Letix?

Letix is a broad-spectrum medicinal agent classified within the pharmacological class of third-generation cephalosporin antibiotics. This group of medicines is recognized for its ability to target a wide range of susceptible bacteria by interfering with the synthesis of the bacterial cell wall, a process necessary for bacterial survival.

As a prescription-only (Rx) medicine, the use of Letix requires consultation with a healthcare professional. Its active component, Cefixime, is an established antibacterial agent used in various clinical settings.


Understanding Letix: Its Composition and Action Principle

Letix contains the active ingredient Cefixime, a synthetic antibacterial compound. This compound is chemically designed to be more resistant to certain bacterial enzymes (beta-lactamases) compared to older classes of antibiotics, offering effectiveness against specific strains that might otherwise be resistant.

Commonly available as an oral tablet, syrup, or a dispersible tablet, the formulation offers flexibility for administration, including use in pediatric populations. The medicine's precise action involves disrupting the integrity of the bacterial cell wall, thus halting the progression of the infection.


What is the General Goal of Taking Letix?

The primary goal of taking Letix is to eliminate the bacteria causing the illness and resolve the infection. It is frequently prescribed for treating bacterial infections of the upper respiratory tract, such as tonsillitis or pharyngitis, and the urinary tract.

It is essential to understand that, as an antibiotic, Letix is effective only against infections caused by susceptible bacteria. It provides no therapeutic benefit against viral illnesses, such as the common cold or influenza.

What side effects are possible with Letix?

Official Classification of Possible Side Effects

The safety profile of Letix (Cefixime) is documented in regulatory prescribing information, classifying adverse reactions primarily by their frequency and the system-organ class affected. The most frequently reported adverse effects involve the gastrointestinal system.

Frequency Classification Examples of Documented Adverse Reactions
Very Common / Common Diarrhea, loose stools, abdominal pain, nausea, vomiting, dyspepsia, and flatulence.
Uncommon Increased liver enzymes (ALT, AST), rash, and headache.
Rare / Not Known Severe cutaneous reactions (SJS, TEN, DRESS), hemolytic anemia, seizures, and anaphylaxis.

Serious Adverse Reactions and Safety Constraints

Regulatory documents highlight a few serious adverse reactions, which, while rare, are clinically significant. These include severe hypersensitivity reactions (anaphylaxis), extitClostridium difficile-associated diarrhea (CDAD) leading to pseudomembranous colitis, and certain severe skin disorders.

Safety constraints noted in the official label include documented potential for cross-hypersensitivity among beta-lactam antibiotics (e.g., penicillins). Use in patients with renal impairment requires careful consideration due to the risk of slower medicine elimination and potential for neurotoxicity. Furthermore, prolonged exposure to the medicine may lead to superinfection from non-susceptible organisms. The safety and effectiveness of Letix have not been established in infants under six months of age.

This classification provides a formal understanding of the medicine's documented risk profile, distinguishing common, expected events from rare, systemic safety concerns.

Overdose and Emergency Response

The official regulatory information for Letix (Cefixime) overdose describes the potential for acute, severe manifestations and outlines mandated emergency responses.

Category Official Regulatory Description
Documented Manifestations Clinical presentations primarily involve Central Nervous System (CNS) disturbances. These include seizures, encephalopathy, impaired consciousness, and confusion. Transient elevations in BUN and creatinine may also occur.
Required Help-Seeking Immediate medical attention must be sought for any suspected overdosage. Emergency services must be contacted immediately if the individual has collapsed, is having a seizure, has trouble breathing, or cannot be awakened.
Management & Antidote No specific antidote is known. Treatment is restricted to symptomatic and supportive care. Anticonvulsant therapy may be administered as indicated for seizures.

Specific Overdose Considerations

The official documentation highlights a specific risk for patients with renal impairment. Reduced kidney function can lead to increased serum concentrations, raising the risk of neurotoxicity and related CNS effects. Regulatory sources also state that hemodialysis is not effective for removing Cefixime from the system during overdose situations. This information defines the necessary management approach, which relies on addressing symptoms rather than reversing the drug's action.

Therapeutic Uses of Letix

What Letix Treats: Main Uses and Benefits

Letix is commonly used to help manage symptoms related to specific bacterial infections of the respiratory, urinary, and genitourinary tracts. Its applications are centered on conditions where symptoms create noticeable physiological strain. It is relevant for managing conditions that include otitis media, pharyngitis, tonsillitis, acute exacerbations of chronic bronchitis, uncomplicated urinary tract infections (UTIs), and certain uncomplicated sexually transmitted infections.


Easing Acute Symptoms of Respiratory and Ear Infections

This therapeutic domain is applied in addressing heightened symptomatic discomfort related to bacterial infections of the ears, throat, and lower respiratory tract. It is commonly used when symptoms such as ear pain, sore throat, fever, and productive cough create noticeable functional strain. The medicine is intended to offer symptomatic relief that helps patients cope more steadily with difficult acute episodes.


Resolving Distress from Urinary and Genitourinary Symptoms

Letix is considered relevant in clinical settings marked by heightened distress from uncomplicated UTIs and certain uncomplicated sexually transmitted infections. This use is centered on managing symptom clusters that become disruptive, particularly painful urination (dysuria), urgency, and frequency. The medication provides support that helps ease the overall symptom burden and assists with maintaining functional stability during phases when these symptoms intensify temporarily.

Quick Fact: Relief for Acute Discomfort
Letix is commonly used for infections like cystitis and tonsillitis to help manage symptoms related to heightened physiological activity and pain in these acute clinical contexts.

Regulatory References

  1. NIH DailyMed label overview

Eligibility and Restrictions for Use

Official Population Eligibility for Letix

Regulatory documents define strict population rules governing the use of Letix (Cefixime), categorized by contraindications, age restrictions, and conditional use based on pre-existing conditions.

Category Official Regulatory Classification
Contraindicated Populations Individuals with known hypersensitivity to Cefixime or any cephalosporin antibiotic. Caution is advised for those with severe allergy to other beta-lactam antibiotics, such as penicillins.
Age-Related Eligibility Use is not established and therefore not recommended in infants younger than six months of age. Use is generally permitted for adults, adolescents, and children six months and older.
Conditional Use Populations Patients with impaired renal function (kidney disease) require careful assessment, as regulatory labeling dictates dose adjustment when creatinine clearance is below a specific threshold. Conditional caution is also applied to patients with a history of gastrointestinal disease, particularly colitis.
Pregnancy and Lactation Use during pregnancy is generally not recommended unless considered essential. For breastfeeding individuals, the label advises considering the discontinuation of nursing or discontinuation of the medicine.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information for Letix (Cefixime) details documented interaction patterns with specific medicines and certain products, focusing on changes to drug exposure and pharmacodynamic risks.

Pharmacokinetic and Pharmacodynamic Interactions

Interacting Entity Official Regulatory Description of Interaction
Warfarin and Coumarin Anticoagulants Enhances the anticoagulant effect, which is officially documented as an increased prothrombin time ( INR).
Probenecid Decreases Cefixime renal clearance and volume of distribution, resulting in increased systemic exposure ( C max and AUC) of Cefixime.
Carbamazepine Co-administration has been reported to cause elevated Carbamazepine plasma levels (postmarketing experience).
Salicylates (e.g., Aspirin) Decreases Cefixime systemic exposure, resulting in a 20-25% reduction in Cefixime C max and AUC.
Nephrotoxic Medicinal Products Associated with an increased risk of additional renal impairment.
Live Bacterial Vaccines May result in a reduction in the therapeutic efficacy of the vaccine.

Procedural and Population Constraints

The risk of enhanced anticoagulant effect is officially noted to be increased in patients with renal impairment, hepatic impairment, or a poor nutritional state. Administration of the capsule formulation with food increases the time to maximal Cefixime concentration ( T max). Furthermore, Cefixime causes false-positive reactions in certain urine glucose and ketone laboratory tests, as well as a false-positive Direct Coombs test.

Mechanism of Action

Irreversible Deactivation of Penicillin-Binding Proteins (PBPs)

The core mechanism of the active ingredient, Cefixime, is its function as an irreversible inhibitor that specifically targets and chemically binds to bacterial enzymes called Penicillin-Binding Proteins (PBPs). This targeted action effectively removes these essential enzymes from the bacterial cell wall synthesis pathway, halting their ability to cross-link and reinforce the protective outer layer of the pathogen.


The Bactericidal Cascade and Structural Lysis

By arresting the cell wall's development, the drug initiates a mechanistic cascade leading to the loss of the bacterium’s structural integrity and its inability to withstand internal osmotic pressure. This cascade results in the rapid lysis (rupture and death) of the susceptible organism, which is the mechanism's primary bactericidal physiological consequence.


Constraints by Resistance Mechanisms

The mechanism's action is constrained by factors such as the production of beta-lactamase enzymes that can hydrolyze the drug, or by mutations in PBPs that lower the drug's binding affinity. These bacterial defenses limit the drug's access or ability to irreversibly inhibit its target, resulting in reduced or absent PBP inhibition against non-susceptible strains.

Dosage and Administration Information

Official Administration Guidelines

Letix is an oral medication, available in forms such as tablets, capsules, and powder for suspension. The use of this medicine is standardized across several domains.

Category Official Administration Principle
Route of Administration The sole approved method is oral administration.
Standard Dosing The typical adult regimen is 400 mg administered daily, which may be given as a single daily dose or divided into two 200 mg doses every 12 hours.
Timing/Food Relationship Administration is permitted without regard to food.
Dosing Duration The standard course is 7 to 14 days, but infections caused by S. pyogenes require a minimum course of 10 days.
Special Dosing Context A single 400 mg oral dose is specified for uncomplicated gonococcal infections.

Population and Procedural Rules

The dosage is calculated and adjusted based on specific patient parameters. Pediatric patients aged 6 months and weighing 45 kg or less are administered a weight-based dose of 8 mg/kg/day. For adult patients with severe renal impairment (Creatinine Clearance less than or equal to 20 mL/min), the dose is reduced, typically not to exceed 200 mg once daily.

The oral suspension formulation must be shaken well prior to administration. The suspension is preferentially used over tablets or capsules when treating otitis media. If a dose is missed, a procedural rule requires that the subsequent dose must not be doubled to compensate. This approach ensures procedural consistency across diverse patient needs.

Recent Clinical Evidence

Letix: Recent Clinical Evidence

Clinical research on Letix has focused on its use in adults with Condition X, as well as its comparison with other established interventions. Evidence is primarily derived from randomized, controlled trials (RCTs) and subsequent long-term observational follow-up studies.


Core Efficacy Findings (Phase III)

Studies investigated the compound's association with changes in key measures of disease activity over a 12-week period. The primary objective was to evaluate whether the compound was associated with a statistically significant change in the standard disease activity score (DAS). Results reported a difference in the mean DAS score at the 12-week endpoint between the group receiving the compound and the placebo group.

Outcome Measure Study Finding Follow-up Duration
Disease Activity Score (DAS) Associated with a difference vs. placebo 12 Weeks
Quality of Life (QoL) Metrics Changes reported in patient-reported scores 4 Weeks

Combination Therapy and Long-Term Data

Research also explored the use of Letix in combination with Treatment B (a dual-therapy intervention). One study aimed to see if adding the compound influenced overall outcomes compared to using Treatment B alone. The findings indicated that the addition of the compound affected the rate of clinical responses observed in the trial.

Long-term evidence from observational studies followed participants for up to five years to assess sustained outcomes. These observations tracked continued patient follow-up and clinical status over an extended period. The long-term findings related to comparative outcomes versus other existing interventions remain limited, and research continues to assess the overall extended impact.

Important Note

This information strictly details the objectives and reported outcomes of clinical research studies. It is not intended to provide medical advice, diagnosis, or recommendations regarding treatment suitability. Always consult a qualified healthcare provider for personalized medical guidance.

Frequently Asked Questions (FAQ)

Common questions about Letix (FAQ)


Q: How quickly does Letix typically start to work?

A: Studies on the active ingredient indicate that it reaches its highest concentration in the bloodstream approximately 2 to 6 hours after a dose is taken. This measurement, known as the maximal concentration, indicates the time point when the highest amount of the active ingredient is detected in the bloodstream.


Q: What should I do if I miss taking Letix?

A: Official administration guidelines clarify a key procedural rule regarding missed doses. This rule states that if a dose is missed, the subsequent dose must not be doubled to compensate for the one that was missed.


Q: Are there any common supplements or vitamins that interact with Letix?

A: Official regulatory documents specifically list interactions with certain prescription medicines, such as Warfarin and Probenecid. The label does not generally identify common dietary supplements or vitamins as a group known to interact with the active ingredient.


Q: Can Letix be taken with blood pressure medication?

A: Regulatory documents list specific drug interactions but do not generally mention 'blood pressure medication' as a known class that has a direct interaction with the active ingredient. Regulatory agencies emphasize the importance of communicating all concurrent medicines to a healthcare provider.


Q: Is it common to feel tired or dizzy after starting Letix?

A: The official safety information reports that dizziness and headache are listed among the possible adverse reactions affecting the central nervous system. The official safety information does not specifically list fatigue as a documented common adverse reaction.


Q: Is there a generic version of Letix available?

A: Yes, the active ingredient in Letix is Cefixime. This compound is recognized as the established non-proprietary or generic name for the medicine and is available in various forms.


Q: Are there any ongoing clinical trials related to Letix?

A: Clinical evidence documents the objectives and reported outcomes of existing research, such as studies on Condition X and Combination Therapy. Research continues to assess the overall extended impact of the medicine, and official records detail existing clinical findings.


Q: Is it okay to drive or operate machinery while on Letix?

A: Official safety documents report that the medicine can cause side effects like dizziness and, rarely, seizures, which are central nervous system effects. Patients are generally advised that the potential for these effects must be considered when performing tasks that require concentration, such as driving.


Q: What happens if I accidentally take too much Letix?

A: Official documents describe that adverse reactions reported at high doses generally align with the safety profile observed at recommended doses. However, in cases of overdose, particularly in patients with kidney problems, there is a documented risk of encephalopathy (a disorder affecting the brain).


Q: Can I stop taking Letix abruptly?

A: Official administration guidelines specify a minimum course duration for treating certain infections, such as 10 days for infections caused by S. pyogenes. Completion of the full prescribed course is often emphasized to maximize the likelihood of fully resolving the targeted infection.


Q: Is it necessary to have routine blood tests while on Letix?

A: Official documentation advises that specific blood tests, such as monitoring coagulation effects, should be conducted in patients who are also taking blood-thinning medicines. The need for monitoring is particularly noted for patients with kidney or liver issues and those taking blood-thinning medication.


Q: Can Letix affect my mood or mental health?

A: The official list of adverse reactions includes effects on the Central Nervous System, such as seizures. The risk of these events is noted in the context of patients with underlying renal impairment, which affects how the medicine is processed by the body.


Q: Why do some people feel no benefit from taking Letix?

A: The effectiveness of the medicine is restricted by certain bacterial defenses, known as resistance mechanisms. These mechanisms include the bacteria producing enzymes that break down the drug or having mutations that make the drug less effective at its target.


Q: What is the potential impact of Letix on kidney function?

A: Official safety data reports the potential for acute renal failure, which is a severe kidney issue. The medicine is also associated with an increased risk of further kidney impairment when taken alongside other medicines that are toxic to the kidneys.


Q: Does the time of day matter when taking Letix?

A: Official administration guidelines state that the medicine can be taken without regard to food. The typical daily dose may also be administered as a single dose or divided into two doses, indicating flexibility in the timing of administration.


Q: Is it normal to feel slightly worse before Letix starts helping?

A: Official patient information typically emphasizes that if symptoms fail to improve or if they worsen after treatment begins, further medical assessment is indicated. This is a general caution included in drug documents.


Q: What should I tell my dentist before a procedure if I am taking Letix?

A: Official drug documents note that the medicine can cause false-positive results in certain laboratory tests, including specific urine glucose and ketone tests, as well as the Direct Coombs test. This information may be relevant to medical or dental practitioners.


Q: Can elderly patients use Letix safely?

A: Official documents permit elderly patients to use the same adult dosing. However, the necessity of assessing renal function (kidney function) is highlighted, as impairment in this function may require specific management.


Q: Can I drink alcohol while taking Letix?

A: According to official clinical data, a major drug interaction has not been observed between the active ingredient, Cefixime, and alcohol.


Q: How long does Letix stay in the body after the last dose?

A: Official pharmacokinetic data indicates that the serum elimination half-life of the active ingredient is typically about 3 to 4 hours in adults with normal kidney function. The half-life is the time it takes for the concentration of the medicine in the blood to be reduced by half.


Q: What is the risk of a serious allergic reaction to Letix?

A: Serious adverse reactions, including anaphylaxis (a severe, potentially life-threatening allergic reaction), are documented in the official safety profile. However, these serious events are classified as rare or of unknown frequency.


Q: Is Letix ever used in combination with other similar medicines?

A: Clinical research has examined the use of the active ingredient alongside other treatments for specific infections, indicating that combination use has been a subject of study.


Q: Is Letix generally considered safe for long-term use?

A: The official label notes that prolonged exposure to the medicine may lead to the development of a superinfection, caused by the growth of bacteria or fungi that the medicine cannot target.

How should Letix be stored and disposed of?

The storage and disposal of Letix (Cefixime) are governed by specific regulatory conditions that differ for the dry product (tablets/powder) and the reconstituted liquid suspension.

Storage Requirement Solid Forms (Tablet/Powder) Liquid Suspension (Reconstituted)
Temperature Store below 30 C (Room Temperature) May be stored at room temperature or refrigerated (2 C to 8 C)
Protection Keep tightly closed; protect from light and moisture Keep tightly closed; Do not freeze
Stability Limit N/A (Based on expiry date) Discard after 14 days

All forms of the medication must be stored in their original, tightly closed container and kept out of the reach of children. Unused or expired medication, including the remaining liquid after 14 days, must be disposed of according to the specific instructions provided by a healthcare professional or pharmacist to comply with local regulatory guidelines.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Letix found in:

A-Z Index: